Skip to main content
Erschienen in: Journal of Gastroenterology 7/2017

05.12.2016 | Original Article—Liver, Pancreas, and Biliary Tract

The 2016 diagnostic criteria for primary sclerosing cholangitis

verfasst von: Takahiro Nakazawa, Kenji Notohara, Susumu Tazuma, Atsushi Tanaka, Hiroyuki Isayama, Toshio Tsuyuguchi, Toshiyuki Mori, Hajime Takikawa

Erschienen in: Journal of Gastroenterology | Ausgabe 7/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease of unknown cause that is characterized pathologically by an inflammatory and fibrotic process centered on the epithelium, leading to diffuse biliary stenosis and increased wall thickness throughout the intra- and extra-hepatic biliary trees. A nationwide survey in Japan revealed several differences in the clinical aspects of PSC between Japan and Western countries. PSC was recently designated an intractable hepatobiliary disease in Japan. The aim of this study was to establish Japanese diagnostic criteria for PSC according to the current Japanese conditions.

Methods

The Intractable Hepato-Biliary Diseases Study Group in Japan of the Committee of Research on Measures for Intractable Diseases established a working group consisting of researchers specializing in PSC and proposed the 2016 Japanese diagnostic criteria for PSC.

Results

The diagnostic criteria consisted of the major and minor items. Major items are directly related to bile duct changes based on biliary tract imaging and an increased alkaline phosphatase level. Minor items consist of an association with inflammatory bowel disease and liver histology.

Conclusion

The diagnostic criteria for PSC are useful for general physicians in practice.
Literatur
1.
Zurück zum Zitat Lazaridis KN, Wiesner RH, Porayko MK, et al. Primary sclerosing cholangitis. In: Schiff ER, Sorrel MF, Maddrey WC, editors. Schiff’s disease of the liver. English edition. Philadelphia: Lippincott-Raven; 1999. p. 649–78. Lazaridis KN, Wiesner RH, Porayko MK, et al. Primary sclerosing cholangitis. In: Schiff ER, Sorrel MF, Maddrey WC, editors. Schiff’s disease of the liver. English edition. Philadelphia: Lippincott-Raven; 1999. p. 649–78.
2.
Zurück zum Zitat Lindor KD, LaRusso NF. Primary sclerosing cholangitis. In: Schiff L, Schiff ER, editors. Schiff’s disease of the liver. 9th ed. Philadelphia: JB Lippincott; 2003. p. 673–84. Lindor KD, LaRusso NF. Primary sclerosing cholangitis. In: Schiff L, Schiff ER, editors. Schiff’s disease of the liver. 9th ed. Philadelphia: JB Lippincott; 2003. p. 673–84.
3.
Zurück zum Zitat Nakazawa T, Ando T, Hayashi K, et al. Diagnostic criteria for IgG4-related sclerosing cholangitis based on cholangiographic classification. J Gastroenterol. 2012;40:79–87.CrossRef Nakazawa T, Ando T, Hayashi K, et al. Diagnostic criteria for IgG4-related sclerosing cholangitis based on cholangiographic classification. J Gastroenterol. 2012;40:79–87.CrossRef
4.
Zurück zum Zitat Ohara H, Okazaki K, Tsubouchi H, et al. Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012. J Hepato Biliary Pancreat Sci. 2012;19:536–42.CrossRef Ohara H, Okazaki K, Tsubouchi H, et al. Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012. J Hepato Biliary Pancreat Sci. 2012;19:536–42.CrossRef
5.
Zurück zum Zitat Takikawa H, Manabe T. Primary sclerosing cholangitis in Japan–analysis of 192 cases. J Gastroenterol. 1997;32:134–7.CrossRefPubMed Takikawa H, Manabe T. Primary sclerosing cholangitis in Japan–analysis of 192 cases. J Gastroenterol. 1997;32:134–7.CrossRefPubMed
6.
Zurück zum Zitat Takikawa H, Takamori Y, Tanaka A, et al. Analysis of 388 cases of primary sclerosing cholangitis in Japan: presence of a subgroup without pancreatic involvement in older patients. Hepatol Res. 2004;29:153–9.CrossRefPubMed Takikawa H, Takamori Y, Tanaka A, et al. Analysis of 388 cases of primary sclerosing cholangitis in Japan: presence of a subgroup without pancreatic involvement in older patients. Hepatol Res. 2004;29:153–9.CrossRefPubMed
7.
Zurück zum Zitat Tanaka A, Tazuma S, Okazaki K, et al. Nationwide survey for primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan. J Hepato Biliary Pancreat Sci. 2014;21:43–50.CrossRef Tanaka A, Tazuma S, Okazaki K, et al. Nationwide survey for primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan. J Hepato Biliary Pancreat Sci. 2014;21:43–50.CrossRef
8.
Zurück zum Zitat Tanaka A, Tazuma S, Okazaki K, et al. Clinical profiles of patients with primary sclerosing cholangitis in the elderly. J Hepato Biliary Pancreat Sci. 2015;22:230–6.CrossRef Tanaka A, Tazuma S, Okazaki K, et al. Clinical profiles of patients with primary sclerosing cholangitis in the elderly. J Hepato Biliary Pancreat Sci. 2015;22:230–6.CrossRef
10.
Zurück zum Zitat Bjornsson E, Olsson R, Bergquist A, et al. The natural history of small-duct primary sclerosing cholangitis. Gastroenterology. 2008;134:975–80.CrossRefPubMed Bjornsson E, Olsson R, Bergquist A, et al. The natural history of small-duct primary sclerosing cholangitis. Gastroenterology. 2008;134:975–80.CrossRefPubMed
11.
Zurück zum Zitat Hirschfield GM, Karlsen TH, Lindor KD, et al. Primary sclerosing cholangitis. Lancet. 2013;382:1587–99.CrossRefPubMed Hirschfield GM, Karlsen TH, Lindor KD, et al. Primary sclerosing cholangitis. Lancet. 2013;382:1587–99.CrossRefPubMed
12.
Zurück zum Zitat Chapman R, Fevery J, Kalloo A, et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010;51:660–78.CrossRefPubMed Chapman R, Fevery J, Kalloo A, et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010;51:660–78.CrossRefPubMed
13.
Zurück zum Zitat Nakazawa T, Ohara H, Sano H, et al. Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis. Gastrointest Endosc. 2004;60:937–44.CrossRefPubMed Nakazawa T, Ohara H, Sano H, et al. Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis. Gastrointest Endosc. 2004;60:937–44.CrossRefPubMed
14.
Zurück zum Zitat Kubota K, Kato S, Uchiyama T, et al. Discrimination between sclerosing cholangitis-associated autoimmune pancreatitis and primary sclerosing cholangitis, cancer using intraductal ultrasonography. Dig Endosc. 2011;23:10–6.CrossRefPubMed Kubota K, Kato S, Uchiyama T, et al. Discrimination between sclerosing cholangitis-associated autoimmune pancreatitis and primary sclerosing cholangitis, cancer using intraductal ultrasonography. Dig Endosc. 2011;23:10–6.CrossRefPubMed
15.
Zurück zum Zitat Naitoh I, Nakazawa T, Hayashi K, et al. Comparison of intraductal ultrasonography findings between primary sclerosing cholangitis and IgG4-related sclerosing cholangitis. J Gastroenterol Hepatol. 2015;30:1104–9.CrossRefPubMed Naitoh I, Nakazawa T, Hayashi K, et al. Comparison of intraductal ultrasonography findings between primary sclerosing cholangitis and IgG4-related sclerosing cholangitis. J Gastroenterol Hepatol. 2015;30:1104–9.CrossRefPubMed
16.
Zurück zum Zitat Itoi T, Kamisawa T, Igarashi Y, et al. The role of peroral video cholangioscopy in patients with IgG4-related sclerosing cholangitis. J Gastroenterol. 2013;48:504–14.CrossRefPubMed Itoi T, Kamisawa T, Igarashi Y, et al. The role of peroral video cholangioscopy in patients with IgG4-related sclerosing cholangitis. J Gastroenterol. 2013;48:504–14.CrossRefPubMed
17.
Zurück zum Zitat Eaton JE, Talwalkar JA, Lazaridis KN, et al. Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management. Gastroenterology. 2013;145:521–36.CrossRefPubMed Eaton JE, Talwalkar JA, Lazaridis KN, et al. Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management. Gastroenterology. 2013;145:521–36.CrossRefPubMed
18.
Zurück zum Zitat Nakazawa T, Naitoh I, Hayashi K, et al. Inflammatory bowel disease of primary sclerosing cholangitis: A distinct entity? World J Gastroenterol. 2014;20:3245–54.CrossRefPubMedPubMedCentral Nakazawa T, Naitoh I, Hayashi K, et al. Inflammatory bowel disease of primary sclerosing cholangitis: A distinct entity? World J Gastroenterol. 2014;20:3245–54.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Loftus EV, Harewood GC, Loftus CG, et al. PSCIBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut. 2005;54:91–6.CrossRefPubMedPubMedCentral Loftus EV, Harewood GC, Loftus CG, et al. PSCIBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut. 2005;54:91–6.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Boonstra K, van Erpecum KJ, van Nieuwkerk KM, et al. Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:2270–6.CrossRefPubMed Boonstra K, van Erpecum KJ, van Nieuwkerk KM, et al. Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:2270–6.CrossRefPubMed
21.
Zurück zum Zitat Sano H, Nakazawa T, Ando T, et al. Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis. J Hepato Biliary Pancreat Sci. 2011;18:154–61.CrossRef Sano H, Nakazawa T, Ando T, et al. Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis. J Hepato Biliary Pancreat Sci. 2011;18:154–61.CrossRef
22.
Zurück zum Zitat Jørgensen KK, Grzyb K, Lundin KE, et al. Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients. Inflamm Bowel Dis. 2012;18:536–45.CrossRefPubMed Jørgensen KK, Grzyb K, Lundin KE, et al. Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients. Inflamm Bowel Dis. 2012;18:536–45.CrossRefPubMed
23.
Zurück zum Zitat Batts KP. Autoimmune and chronic cholestatic disorders of the liver. In: Odze RD, Goldblum JR, editors. Surgical Pathology of the GI tract, liver, biliary tract, and pancreas. 3rd ed. Philadelphia: Elsevier; 2015. p. 1262–84. Batts KP. Autoimmune and chronic cholestatic disorders of the liver. In: Odze RD, Goldblum JR, editors. Surgical Pathology of the GI tract, liver, biliary tract, and pancreas. 3rd ed. Philadelphia: Elsevier; 2015. p. 1262–84.
24.
Zurück zum Zitat Nakanuma Y, Yamaguchi K, Ohta G, et al. Pathological features of hepatolithiasis in Japan. Hum Pathol. 1988;19:1181–6.CrossRefPubMed Nakanuma Y, Yamaguchi K, Ohta G, et al. Pathological features of hepatolithiasis in Japan. Hum Pathol. 1988;19:1181–6.CrossRefPubMed
25.
Zurück zum Zitat Torbenson MS. Biopsy interpretation of the liver. Philadelphia: Wolter’s Kluwer Health; 2015. Torbenson MS. Biopsy interpretation of the liver. Philadelphia: Wolter’s Kluwer Health; 2015.
26.
Zurück zum Zitat Lindor KD, Kowdley KV, Harrison E. ACG clinical guideline: primary sclerosing cholangitis. Am J Gastroenterol. 2015;110:646–59.CrossRefPubMed Lindor KD, Kowdley KV, Harrison E. ACG clinical guideline: primary sclerosing cholangitis. Am J Gastroenterol. 2015;110:646–59.CrossRefPubMed
Metadaten
Titel
The 2016 diagnostic criteria for primary sclerosing cholangitis
verfasst von
Takahiro Nakazawa
Kenji Notohara
Susumu Tazuma
Atsushi Tanaka
Hiroyuki Isayama
Toshio Tsuyuguchi
Toshiyuki Mori
Hajime Takikawa
Publikationsdatum
05.12.2016
Verlag
Springer Japan
Erschienen in
Journal of Gastroenterology / Ausgabe 7/2017
Print ISSN: 0944-1174
Elektronische ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-016-1286-x

Weitere Artikel der Ausgabe 7/2017

Journal of Gastroenterology 7/2017 Zur Ausgabe

Original Article—Liver, Pancreas, and Biliary Tract

Quantitative diagnosis of chronic pancreatitis using EUS elastography

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.